Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice

Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH). Surprisingly, however, the assumption that tPA will worsen I...

詳細記述

保存先:
書誌詳細
主要な著者: Foerch, Christian, Rosidi, Nathanael L., Schlunk, Frieder, Lauer, Arne, Cianchetti, Flor A., Mandeville, Emiri, Arai, Ken, Yigitkanli, Kazim, Fan, Xiang, Wang, Xiaoying, van Leyen, Klaus, Steinmetz, Helmuth, Schaffer, Chris B., Lo, Eng H.
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568130/
https://ncbi.nlm.nih.gov/pubmed/23408937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054203
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料